Literature DB >> 6332885

Local and systemic immune response in multiple sclerosis: analysis of CSF inflammatory changes and peripheral blood T-cell subsets.

A J Steck, J C de Flaugergues.   

Abstract

In order to investigate the significance of the immune response in multiple sclerosis (MS), we have compared changes in peripheral blood T-cell subsets to the cellular and humoral responses in the cerebrospinal fluid. Using monoclonal antibodies defining the Leu-3a and Leu-2a phenotypes, we found a highly significant (2P less than 0.001) increase of the Leu-3a/Leu-2a cell ratio in peripheral blood T-cells of multiple sclerosis patients with disease activity (acute phase or progressive form), while patients with inactive disease did not differ from controls. No characteristic alterations in the CSF inflammatory response could be correlated with changes in T-cell subsets in the peripheral blood. There was no significant difference in the cerebrospinal fluid cell count or the mean IgG index between patients with high or low Leu-3a/Leu-2a cell ratios. We conclude that increased CSF IgG synthesis in MS is probably not a direct consequence of the apparent reduction of Leu-2a positive cells in the peripheral blood. Thus the biological significance of the change in immunoregulatory cells in the blood of multiple sclerosis patients remains unknown.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6332885     DOI: 10.1007/bf00313679

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

2.  The immune system and the nervous system.

Authors:  J A Aarli
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

3.  Sequential changes in oligoclonal patterns during the course of multiple sclerosis.

Authors:  E J Thompson; P Kaufmann; P Rudge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-02       Impact factor: 10.154

4.  T-lymphocyte subsets in cerebrospinal fluid in multiple sclerosis.

Authors:  H S Panitch; G S Francis
Journal:  N Engl J Med       Date:  1982-08-26       Impact factor: 91.245

5.  Viral antibodies in multiple sclerosis.

Authors:  E Norrby
Journal:  Prog Med Virol       Date:  1978

6.  The enigma of oligoclonal immunoglobulin G in cerebrospinal fluid from multiple sclerosis patients.

Authors:  P Y Paterson; C C Whitacre
Journal:  Immunol Today       Date:  1981-06

7.  IgG ratios and oligoclonal IgG in multiple sclerosis and other neurological disorders.

Authors:  G D Perkin; K Sethi; B R Muller
Journal:  J Neurol Sci       Date:  1983 Aug-Sep       Impact factor: 3.181

8.  Lymphocyte populations in the cerebrospinal fluid and peripheral blood of patients with multiple sclerosis and optic neuritis.

Authors:  M Sandberg-Wollheim
Journal:  Scand J Immunol       Date:  1983-06       Impact factor: 3.487

9.  Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.

Authors:  C Confavreux; G Aimard; M Devic
Journal:  Brain       Date:  1980-06       Impact factor: 13.501

10.  Multiple sclerosis: distribution of T cell subsets within active chronic lesions.

Authors:  U Traugott; E L Reinherz; C S Raine
Journal:  Science       Date:  1983-01-21       Impact factor: 47.728

View more
  3 in total

1.  Cell count and ratio of helper/inducer to suppressor/cytotoxic T-cells in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  H W Kölmel; C Sudau
Journal:  J Neurol       Date:  1989-10       Impact factor: 4.849

2.  Dual labelling of circulating CD8 cells in patients with multiple sclerosis.

Authors:  P J Hughes; P F Kirk; D A Compston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

3.  T cell subsets in AIDS: relationships between peripheral blood and cerebrospinal fluid.

Authors:  A Steck; J C de Flaugergues
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-02       Impact factor: 10.154

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.